MF-8, a novel promising arylpiperazine-hydantoin based 5-HT7 receptor antagonist: In vitro drug-likeness studies and in vivo pharmacological evaluation
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 28 (5) , 878-883
Abstract
No abstract availableKeywords
Funding Information
- Jagiellonian University Medical College
- National Science Centre (UMO-2014)
- Jagiellonian University Medical College
This publication has 31 references indexed in Scilit:
- Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to DateCNS Drugs, 2015
- SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT7 receptor ligands among phenylpiperazine hydantoin derivativesEuropean Journal of Medicinal Chemistry, 2014
- The serotonin 5-HT7 receptors: two decades of researchExperimental Brain Research, 2013
- Towards metabolically stable 5-HT7 receptor ligands: a study on 1-arylpiperazine derivatives and related isostersExperimental Brain Research, 2013
- The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micellesBiomaterials, 2011
- Pharmacophore models based studies on the affinity and selectivity toward 5-HT1A with reference to α1-adrenergic receptors among arylpiperazine derivatives of phenytoinBioorganic & Medicinal Chemistry, 2011
- Search for influence of spatial properties on affinity at α1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoinBioorganic & Medicinal Chemistry Letters, 2010
- Synthesis, α1-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoinBioorganic & Medicinal Chemistry, 2008
- A Novel Design of Artificial Membrane for Improving the PAMPA ModelPharmaceutical Research, 2008
- Aminotriazine 5-HT7 antagonistsBioorganic & Medicinal Chemistry Letters, 2004